Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Irritable Bowel Syndrome, October 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 106 articles:
HTML format


 

Single Articles

  1. DE WAAL D
    Nickel Allergy Masquerading as Irritable Bowel Syndrome- Case Report.
    J Acad Nutr Diet. 2025 Oct 1:S2212-2672(25)00790.
    PubMed    
    Abstract available

  2. ROBBERTZ AS, Nelson CI, Peugh J, Hommel K, et al
    The Relations Among GI Symptoms, Mental Health, and Online Schooling for Youth With GI Conditions During the COVID-19 Pandemic.
    J Dev Behav Pediatr. 2025 Oct 3. doi: 10.1097/DBP.0000000000001429.
    PubMed    
    Abstract available

  3. HOU Y, Luo F, Wang K, Chen Y, et al
    Electroacupuncture restores intestinal mucosal barrier in IBS-D rats by modulating mast cell-derived exosomal MiR-149-5p.
    Front Immunol. 2025;16:1641484.
    PubMed    
    Abstract available

  4. RAHMDEL S, Luqman A, Gotz F
    Microbiota-derived aromatic amino acid decarboxylases: linking microbial fitness and host neurochemical communication.
    mBio. 2025 Oct 2:e0205225. doi: 10.1128/mbio.02052.
    PubMed    
    Abstract available

  5. KE W, Huang S, Zhu H, Tan Q, et al
    Changji'an formula alleviates visceral hypersensitivity of a post-inflammatory IBS-D mouse model via NGF/TrkA signaling pathway.
    BMC Complement Med Ther. 2025;25:348.
    PubMed    
    Abstract available

  6. AKCALI C, Ucar A, Atay K
    A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation predominant IBS.
    Sci Rep. 2025;15:34252.
    PubMed    
    Abstract available

  7. KERBAGE A, Wu Y, Yang Q, Simons M, et al
    Associations Between Sexual Orientation and Disorders of Gut-Brain Interaction in Sexual Minority Populations.
    Clin Gastroenterol Hepatol. 2025 Sep 29:S1542-3565(25)00842.
    PubMed    
    Abstract available

  8. SUMMIT AG, Lin HC, Wisner KM, Chen C, et al
    Assessing the association between child maltreatment and chronic pain: a cross-sectional co-twin control study.
    Pain. 2025 Oct 1. doi: 10.1097/j.pain.0000000000003809.
    PubMed    
    Abstract available

  9. SOINI T, Andersson F, Lalouni M, Bonnert M, et al
    Hypnotherapy self-exercises with audio files for children and adolescents with disorders of gut-brain interaction-a study of feasibility and preliminary effects in Sweden.
    Therap Adv Gastroenterol. 2025;18:17562848251381141.
    PubMed    
    Abstract available

  10. CUFFE MS, Goodoory VC, Ng CE, Black CJ, et al
    Epidemiology of Meal-Related Abdominal Discomfort or Pain in Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Sep 30:e70174. doi: 10.1111/nmo.70174.
    PubMed    
    Abstract available

  11. KARACAN Y, Demirayak D, Parlak AG
    The Invisible Link Between Mind and Gut: The Effect of Alexithymia and Adjustment to Illness on Symptom Severity in IBS Patients With Rome IV Criteria.
    Neurogastroenterol Motil. 2025 Sep 30:e70176. doi: 10.1111/nmo.70176.
    PubMed    
    Abstract available

  12. LAMBIASE CV, Guiso M, Pesce M, Vendemmia M, et al
    The relationship among NICU stressors and irritable bowel syndrome in parents during their infant stay: the mediating role of anxiety.
    Ital J Pediatr. 2025;51:277.
    PubMed    
    Abstract available

  13. CAMINITI L, Arasi S, Barni S, Castagnoli R, et al
    Eosinophilic gastroduodenitis: a pediatric perspective.
    Ital J Pediatr. 2025;51:278.
    PubMed    
    Abstract available

  14. WANG K, Alam MJ, Lan X, Li F, et al
    Efficacy and mechanisms of neuromodulation in the treatment of irritable bowel syndrome.
    Bioelectron Med. 2025;11:23.
    PubMed    
    Abstract available

  15. KUON C
    It Is Time for a New IBS Paradigm.
    Glob Adv Integr Med Health. 2025;14:27536130251383554.
    PubMed    
    Abstract available

  16. KANG H, Chen Z, Wang B, Chen Z, et al
    The AhR/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects.
    Front Immunol. 2025;16:1668173.
    PubMed    
    Abstract available

  17. LAM WC, Chen H, Siah KTH, Thakur ER, et al
    Electro-acupuncture for irritable bowel syndrome with constipation: study protocol of a pilot, randomized, double-blinded, sham-controlled trial.
    Front Neurol. 2025;16:1632822.
    PubMed    
    Abstract available

  18. COLBRAN R, Neshatian L
    Laxative logic: when lifestyle is not enough.
    Curr Opin Gastroenterol. 2025 Sep 25. doi: 10.1097/MOG.0000000000001137.
    PubMed    
    Abstract available

  19. LAKEMEYER M, Latorre R, Blazkova K, Wood HM, et al
    A Bacteroides fragilis protease activates host PAR(2) to induce intestinal pain and inflammation.
    Cell Host Microbe. 2025 Sep 26:S1931-3128(25)00376.
    PubMed    
    Abstract available

  20. DIMITRIOU A, Aggeletopoulou I, Triantos C
    Optimizing Nutritional Balance: Integrating the Mediterranean Diet into Low-FODMAP Nutrition.
    Microorganisms. 2025;13:2085.
    PubMed    
    Abstract available

  21. ROTH B, Ohlsson B
    Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials.
    Nutrients. 2025;17:2966.
    PubMed    
    Abstract available

  22. WU W, Chen J, Li A, Chen MH, et al
    Mechanistic Insights into a Self-Management Intervention in Young Adults with Irritable Bowel Syndrome: A Pilot Multi-Omics Study.
    Biomedicines. 2025;13:2102.
    PubMed    
    Abstract available

  23. DE SILVA AP, Prabagar K, Niriella MA, De Silva HJ, et al
    Management of Irritable Bowel Syndrome: The Role of Digital Health Technologies.
    J Gastrointestin Liver Dis. 2025;34:275-278.
    PubMed    
    Abstract available

  24. DARDMEH N, Moazzami AA, Yavarmanesh M, Matin MM, et al
    Effect of probiotic administration of Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 on metabolic profiles in an IBS-D rat model: a metabolomic analysis approach.
    J Sci Food Agric. 2025 Sep 26. doi: 10.1002/jsfa.70190.
    PubMed    
    Abstract available

  25. KERREBIJN I, Bjornsdottir G, Arbabi K, Urpa L, et al
    The genetic architecture of fibromyalgia across 2.5 million individuals.
    medRxiv [Preprint]. 2025 Sep 19:2025.09.18.25335914.
    PubMed    
    Abstract available

  26. XI W, Feng R, Li J, Bai X, et al
    Evaluating the content and quality of irritable bowel syndrome videos on social media platforms in China: Focus on TikTok and Bilibili.
    Digit Health. 2025;11:20552076251382029.
    PubMed    
    Abstract available

  27. YU J, Shen Y, Wang Z, Shen W, et al
    The relationship between insomnia and multiple gastrointestinal disorders: a Mendelian randomization study.
    BMC Gastroenterol. 2025;25:643.
    PubMed    
    Abstract available

  28. TANG J, Krushelnycky L, Shaqo A, Cho CE, et al
    A comprehensive review of nutritional influences on the serotonergic system.
    Adv Nutr. 2025 Sep 23:100524. doi: 10.1016/j.advnut.2025.100524.
    PubMed    
    Abstract available

  29. BAI W, Zheng Y, Pan Y, Zhuang M, et al
    Sex-specific analyses of early-life tobacco smoke exposure and later-life irritable bowel syndrome: Sensitive window, mediation pathway, and genetic predisposition.
    Ecotoxicol Environ Saf. 2025;304:119099.
    PubMed    
    Abstract available

  30. GHEGA H, Ali Z, Sohail S, Singla S, et al
    Efficacy of Dietary Interventions in Managing Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes and Gut Microbiota Modulation.
    Cureus. 2025;17:e90889.
    PubMed    
    Abstract available

  31. MUZELLINA VN, Widjanarko ND, Subagya JC, Alvianto S, et al
    Chromogranin A as a Novel Biomarker of Irritable Bowel Syndrome in Adults: A Systematic Review and Meta-Analysis.
    Middle East J Dig Dis. 2025;17:128-138.
    PubMed    
    Abstract available

  32. ARCOT D, Pondicherry N, Chakraborty S
    Evaluating the Quality of Health Information: Comparison of Human and Artificial Intelligence.
    Neurogastroenterol Motil. 2025 Sep 24:e70164. doi: 10.1111/nmo.70164.
    PubMed    
    Abstract available

  33. SEGUELLA L, Thomasi B, Basili Franzin S, McClain JL, et al
    Hyperactive enteric glia contribute to persistent dysmotility following inflammation by driving aberrant excitatory responses in neurons.
    Cell Mol Gastroenterol Hepatol. 2025 Sep 22:101634.
    PubMed    
    Abstract available

  34. CRICRI M, Luglio G, Tropeano F, Miele A, et al
    Prevalence of temporomandibular disorder in irritable bowel syndrome (IBS) patients: a systematic review.
    J Oral Facial Pain Headache. 2025;39:66-74.
    PubMed    
    Abstract available

  35. TANG B, Mei Z, Chen J, Yu G, et al
    Relationships Among Gut Microbiota, Plasma Inflammatory Cytokines, and Irritable Bowel Syndrome: A Mediation Mendelian Randomization Study.
    Neurogastroenterol Motil. 2025 Oct 9:e70178. doi: 10.1111/nmo.70178.
    PubMed    
    Abstract available

  36. LI Y, Liu S, Zhang Q, Zhang S, et al
    Dietary index for gut microbiota and risk of incident irritable bowel syndrome: a large-scale prospective cohort study.
    Nutr J. 2025;24:157.
    PubMed    
    Abstract available

  37. YUAN Z, Yang X, Wang X, Shi X, et al
    Melatonin alleviates diarrhea and visceral hypersensitivity in rats with diarrhea-predominant irritable bowel syndrome by modulating of the TLR4/MyD88/NF-kappaB pathway.
    BMC Gastroenterol. 2025;25:715.
    PubMed    


  38. SHIN AS, Xing Y, Waseem MR, Siwiec R, et al
    Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS).
    Sci Rep. 2025;15:35375.
    PubMed    
    Abstract available

  39. DUAN S, Kanda H, Zhu F, Okubo M, et al
    Sympathetic Overactivation Drives Colonic Eosinophil Infiltration Linked to Visceral Hypersensitivity in Irritable Bowel Syndrome.
    Cell Mol Gastroenterol Hepatol. 2025 Oct 7:101658.
    PubMed    
    Abstract available

  40. AUMPAN N, Chonprasertsuk S, Pornthisarn B, Siramolpiwat S, et al
    Efficacy of encapsulated fecal microbiota transplantation and FMT via rectal enema for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial (CAP-ENEMA FMT Trial).
    Front Med (Lausanne). 2025;12:1648944.
    PubMed    
    Abstract available

  41. CHI TK, My NTL, Yen HH, Ngoc DTQ, et al
    Role of Anti-Vinculin Quantitative ELISA Test in Diagnosing Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    Med Arch. 2025;79:287-291.
    PubMed    
    Abstract available

  42. KOU RW, Zhang RJ, Xia B, Bai GY, et al
    Ergosterol Regulates Visceral Hypersensitivity and Intestinal Motility in Irritable Bowel Syndrome Through Microbiota-Metabolites-AhR Signaling Axis.
    J Agric Food Chem. 2025 Oct 8. doi: 10.1021/acs.jafc.5c11549.
    PubMed    
    Abstract available

  43. BARREIRINHAS S, Almeida C, Casal S, Padrao P, et al
    Pre-packaged food targeted to gastrointestinal pathologies: are they low in FODMAP?
    Br J Nutr. 2025 Oct 9:1-16. doi: 10.1017/S000711452510528.
    PubMed    
    Abstract available

  44. PETERSSON A, Roth B, Becker C, Ohlsson B, et al
    Elevated levels of TRAb IgG autoantibodies are not recognized in endometriosis by the current clinical methods.
    Front Med (Lausanne). 2025;12:1612079.
    PubMed    
    Abstract available

  45. WANG T, Yang P, Dong S, He X, et al
    Cold-inducible RNA-binding protein promotes gut barrier dysfunction and visceral hypersensitivity via activating mast cells in IBS-D.
    Int Immunopharmacol. 2025;166:115640.
    PubMed    
    Abstract available

  46. SUMBIZI CE, Hassan O, Mbuma R, Kifaluka J, et al
    Post-cholecystectomy bile acid diarrhea in a teenager with sickle cell disease: Case report.
    Int J Surg Case Rep. 2025;136:112018.
    PubMed    
    Abstract available

  47. DU J-Y, Zhang Z-J, Tan L, Yang J-Y, et al
    Gut microbiota dysbiosis and metabolic perturbations of bile/glyceric acids in major depressive disorder with IBS comorbidity.
    mBio. 2025 Oct 7:e0244725. doi: 10.1128/mbio.02447.
    PubMed    
    Abstract available

  48. EISELE M, Yousuf M, Haskey N, D'Silva A, et al
    Smartphone Application With Health Coaching Facilitates Multi-Symptom Improvement in IBS Patients: A Pilot Feasibility Trial.
    Neurogastroenterol Motil. 2025 Oct 7:e70179. doi: 10.1111/nmo.70179.
    PubMed    
    Abstract available

  49. KHAMAAL HUSSEIN ABOD AL-KHAFAJ, Zahraa Mohammed Fakheir, Shaimaa Mohammed Ali Jasim
    Bitter frankincense water modulates hepatic enzyme activity in female patients with irritable bowel syndrome.
    Cell Mol Biol (Noisy-le-grand). 2025;71:80-85.
    PubMed    
    Abstract available

  50. AFFAITATI G, Costantini R, Wesselmann U, Czakanski P, et al
    Impact of visceral pain on migraine symptoms in comorbid patients: a retrospective observational study.
    J Headache Pain. 2025;26:217.
    PubMed    
    Abstract available

  51. CEULEMANS M, Wauters L, Broeders B, Schol J, et al
    Symptoms but not physiology differentiate functional dyspepsia with or without overlapping gastrointestinal disorders.
    Clin Transl Gastroenterol. 2025 Oct 16. doi: 10.14309/ctg.0000000000000938.
    PubMed    
    Abstract available

  52. GUO K, Zou J, Tang Y
    Commentary: Wuling powder ameliorates diarrhea-predominant irritable bowel syndrome in mice by modulating gut mucosal microbiota and alleviating intestinal inflammation.
    Front Cell Infect Microbiol. 2025;15:1694104.
    PubMed    


  53. VAN DEN ABBEELE P, Poppe J, Baudot A, Vu LD, et al
    Triacetin and a Mushroom Blend Restore Butyrate Production by IBS Microbiomes Ex Vivo, Thus Promoting Barrier Integrity.
    Int J Mol Sci. 2025;26:9388.
    PubMed    
    Abstract available

  54. ZAFAR A, Lahori D, Namit AF, Paxton Z, et al
    Curcumin in Inflammatory Complications: Therapeutic Applications and Clinical Evidence.
    Int J Mol Sci. 2025;26:9366.
    PubMed    
    Abstract available

  55. ABALO R, Gallego-Barcelo P, Gabbia D
    Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
    Int J Mol Sci. 2025;26:9345.
    PubMed    
    Abstract available

  56. YAN Y, Liu L, Shen XJ
    Comment on "Prevalence of irritable bowel syndrome in endometriosis patients: A cross-sectional study".
    J Family Med Prim Care. 2025;14:4093-4094.
    PubMed    


  57. LIN H, Zhang N, Diao T, Yu L, et al
    [Efficacy analysis of anti-migraine therapy for acute low-frequency hearing loss and investigation of its mechanisms].
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025;39:907-911.
    PubMed    
    Abstract available

  58. OZYURT NK, Kisioglu M, Guven B, Yildiz N, et al
    Linking IgE-mediated CMPA to functional gastrointestinal disorders.
    Eur J Pediatr. 2025;184:688.
    PubMed    
    Abstract available

  59. VAN OUYTSEL P, Egret A, Piessevaux H, Louis H, et al
    Fermentable Oligo-Di-Mono-saccharides And Polyols (FODMAP) consumption in Belgian healthy adults and irritable bowel syndrome patients.
    Acta Gastroenterol Belg. 2025;88:253-258.
    PubMed    
    Abstract available

  60. DIMIDI E, van der Schoot A, Barrett K, Farmer AD, et al
    British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in Adults.
    J Hum Nutr Diet. 2025;38:e70133.
    PubMed    
    Abstract available


  61. Correction to "Efficacy of the Enteroadsorbent Silicol(R)gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study".
    Gastroenterol Res Pract. 2025;2025:9856930.
    PubMed    
    Abstract available

  62. HASHIM S, Wang S, Burr B, Tadwalkar S, et al
    Treatment of Irritable Bowel Syndrome With Antispasmolytics in Taiwan, Hong Kong, and Vietnam: A Delphi Expert Consensus Statement.
    J Neurogastroenterol Motil. 2025;31:512-526.
    PubMed    
    Abstract available

  63. LEE HK, Shin CM, Chang YH, Jo H, et al
    Predictors of Treatment Response to Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Pilot Study.
    J Neurogastroenterol Motil. 2025;31:462-476.
    PubMed    
    Abstract available

  64. VARNEY JE, Madan J, Halmos EP, Krishnasamy S, et al
    Implementing a Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet in Asia: Addressing Cultural, Clinical and Practical Challenges.
    J Neurogastroenterol Motil. 2025;31:422-437.
    PubMed    
    Abstract available

  65. GWEON TG
    Is Fecal Microbiota Transplantation Applicable for the Treatment of Irritable Bowel Syndrome? Time for Precision Medicine.
    J Neurogastroenterol Motil. 2025;31:403-404.
    PubMed    


  66. THAKUR ER, Khasawneh M, Moayyedi P, Black CJ, et al
    Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis.
    Lancet Gastroenterol Hepatol. 2025 Oct 9:S2468-1253(25)00238.
    PubMed    
    Abstract available

  67. ABBER SR, Burton-Murray H
    Evidence without evolution: a call for precision behavioural therapy in irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2025 Oct 9:S2468-1253(25)00284.
    PubMed    


  68. XIE L, Zhou W, Tang Y, Yi Y, et al
    ISRIB inhibits endoplasmic reticulum stress to ameliorate chronic restraint stress-induced intestinal inflammation.
    Eur J Pharmacol. 2025;1007:178236.
    PubMed    
    Abstract available

  69. KAUFMANN H, Duboc H, Freiche V
    Functional dyspepsia: from human to dog, a retrospective study of 29 cases illustrating a complex entity.
    BMC Vet Res. 2025;21:600.
    PubMed    
    Abstract available

  70. WILCOX CM, Tran H
    FECAL ELASTASE MEASUREMENT- BEWARE; A CAUTIONARY TALE.
    Am J Med Sci. 2025 Oct 21:S0002-9629(25)01255.
    PubMed    
    Abstract available

  71. WU G, Fang Y, Hong Y, Zhu J, et al
    Evaluating the impact of obstructive sleep apnea-hypopnea syndrome on irritable bowel syndrome.
    Sleep Med. 2025;136:106865.
    PubMed    
    Abstract available

  72. WOODS AT, Ford AC, Black CJ
    All in my head or all in my gut? An update on irritable bowel syndrome.
    Curr Opin Gastroenterol. 2025 Oct 23. doi: 10.1097/MOG.0000000000001141.
    PubMed    
    Abstract available

  73. ZHANG X, Li Y, Guo Y, Sun J, et al
    Clinical efficacy of fecal microbiota transplantation in alleviating depressive symptoms: a meta-analysis of randomized trials.
    Front Psychiatry. 2025;16:1656969.
    PubMed    
    Abstract available

  74. YASUKAWA T, Yamazato Y, Tanobe K, Machida M, et al
    Effect of Stretching on the Electroencephalography of People With Irritable Bowel Syndrome.
    Cureus. 2025;17:e92709.
    PubMed    
    Abstract available

  75. PETERSSON A, Roth B, Jokubkiene L, Sladkevicius P, et al
    Comparison of sociodemographic factors, lifestyle, and gastrointestinal symptoms between patients with endometriosis and IBS.
    BMC Gastroenterol. 2025;25:742.
    PubMed    
    Abstract available

  76. MORETTI CH, Grasset E, Zhu J, Yang G, et al
    Identification of human gut bacteria that produce bioactive serotonin and promote colonic innervation.
    Cell Rep. 2025 Oct 20:116434. doi: 10.1016/j.celrep.2025.116434.
    PubMed    
    Abstract available

  77. GOUDARZI A, Karami T, Abdelamir Mohammad H, Akrami M, et al
    Dual Extrusion-based 3D-Printed Core-Shell Tablets for Colorectal Delivery of Mebeverine Hydrochloride.
    Drug Dev Ind Pharm. 2025 Oct 21:1-42. doi: 10.1080/03639045.2025.2573673.
    PubMed    
    Abstract available

  78. DERAISON C, Vergnolle N
    Proteases in intestinal health and disease.
    Nat Rev Gastroenterol Hepatol. 2025 Oct 20. doi: 10.1038/s41575-025-01129.
    PubMed    
    Abstract available

  79. SCHIEL K, Chrusciel T, Gruzca R, Scherrer JF, et al
    Gastrointestinal Conditions and New Diagnosis of Alcohol Use Disorder.
    J Am Board Fam Med. 2025 Oct 20. doi: 10.3122/jabfm.2024.240426.
    PubMed    
    Abstract available

  80. YU D, Tian Q, Shen J, Fang L, et al
    Deciphering the microbiological mechanism of Tongxie Yaofang in treating IBS-D: a multimodal mechanistic study in mice integrating network pharmacology, computational simulation, and 16S rRNA sequencing.
    Exp Biol Med (Maywood). 2025;250:10725.
    PubMed    
    Abstract available

  81. ZHANG P, Chen Y, Lai B, Wang S, et al
    Comparison of acupuncture, moxibustion, and pharmacotherapy in improving diarrhea-predominant irritable bowel syndrome.
    Front Microbiol. 2025;16:1638930.
    PubMed    
    Abstract available

  82. TU H, Xu J, Wei L, Kong Z, et al
    Comparison with healthy controls: meta-analysis of changes in intestinal flora in Chinese patients with irritable bowel syndrome.
    Front Cell Infect Microbiol. 2025;15:1657501.
    PubMed    
    Abstract available

  83. HANNA-JAIRALA I, Puentes-Leal GA, Madrid AM, Aguilar-Paiz L, et al
    Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and treatment of irritable bowel syndrome in clinical practice.
    Rev Gastroenterol Mex (Engl Ed). 2025 Oct 18:S2255-534X(25)00121.
    PubMed    
    Abstract available

  84. HONG G, Zhao Y, Hou X
    Impact of four-week rifaximin treatment on abdominal symptoms, psychological state and gut microbiome in diarrhea-predominant irritable bowel syndrome: a pilot study.
    Eur J Pharmacol. 2025;1007:178271.
    PubMed    
    Abstract available

  85. PAVAN F, Yadav SS, Costantino A, Dell'Era A, et al
    The Effectiveness of Yoga for Irritable Bowel Syndrome: A Systematic Review.
    Compr Physiol. 2025;15:e70061.
    PubMed    
    Abstract available

  86. BUTT MF, Goodoory VC, Ng CE, Black CJ, et al
    Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom.
    Aliment Pharmacol Ther. 2025 Oct 8. doi: 10.1111/apt.70400.
    PubMed    
    Abstract available

  87. CHUAH KH, Loo QY, Loh AJC, Leong JY, et al
    Clinical Trial: Rifaximin Versus Low FODMAP Diet in Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Oct 16. doi: 10.1111/apt.70420.
    PubMed    
    Abstract available

  88. DILMAGHANI S, BouSaba J, Lupianez-Merly C, Prokop L, et al
    Meta-Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea.
    Aliment Pharmacol Ther. 2025 Oct 15. doi: 10.1111/apt.70390.
    PubMed    
    Abstract available

  89. SHIN A, Xu H, Sarnoff R, Church A, et al
    Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025;62:944-947.
    PubMed    
    Abstract available

  90. TORNKVIST N, Palsson OS, Hreinsson J, Sperber AD, et al
    Global prevalence, characterization and impact of Functional Bowel Disorders.
    Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003782.
    PubMed    
    Abstract available

  91. VAN OUYTSEL P, Szalai A, Egret A, Kristanto P, et al
    Development and Validation of a Self-Administered Simplified Food Frequency Questionnaire for FODMAP Intake Evaluation (FFQ-FODMAP-BE).
    Dig Dis Sci. 2025 Oct 15. doi: 10.1007/s10620-025-09460.
    PubMed    
    Abstract available

  92. CHANG A, Oh J, Shin A, Oser M, et al
    Similar Symptoms, Distinct Syndromes: Multi-modal Approach to the Patient with an IBD-IBS Overlap.
    Dig Dis Sci. 2025 Oct 18. doi: 10.1007/s10620-025-09473.
    PubMed    
    Abstract available

  93. GOYAL O, Goyal MK, Gupta A, Bharadwaj A, et al
    Prevalence and predictors of nonceliac wheat sensitivity in refractory irritable bowel syndrome and functional dyspepsia: results from a randomized double-blind placebo-controlled study.
    Eur J Gastroenterol Hepatol. 2025;37:1238-1248.
    PubMed    
    Abstract available

  94. LIU Y, Pan X
    Effect of Cognitive Behavior Therapy on the Mental Health of Patients With Irritable Bowel Syndrome: A Systematic Review.
    Gastroenterol Nurs. 2025 Oct 22. doi: 10.1097/SGA.0000000000000927.
    PubMed    
    Abstract available

  95. LONG Q
    Analysis of "Mebeverine and the Influence of Labeling in Adolescents With Irritable Bowel Syndrome or Functional Abdominal Pain Not Otherwise Specified: A 2 x 2 Randomized, Placebo-Controlled Trial".
    Gastroenterology. 2025 Oct 18:S0016-5085(25)05890.
    PubMed    


  96. SCHMELTER F, Schroder T, Laumonnier Y, Bischoff SC, et al
    Impaired glucose metabolism in irritable bowel syndrome: personalised low-glycaemic diet as potential therapeutic target.
    Gut. 2025 Oct 5:gutjnl-2025-336797. doi: 10.1136/gutjnl-2025-336797.
    PubMed    


  97. TANNOUS S, Husein DM, Naim HY
    Congenital sucrase-isomaltase mutations worsen IBS-linked V15F dysfunction and trafficking.
    Gut. 2025 Oct 21:gutjnl-2025-336813. doi: 10.1136/gutjnl-2025-336813.
    PubMed    


  98. RUILOVA SOSORANGA E, Tack J
    Insulin-like peptide 5: a new key player in IBS with diarrhoea and bile acid malabsorption?
    Gut. 2025 Oct 17:gutjnl-2025-336390. doi: 10.1136/gutjnl-2025-336390.
    PubMed    


  99. SONG H, Zhou Y, Liu S, Zhang Q, et al
    Long-term risk of inflammatory bowel disease in patients with irritable bowel syndrome: the cross-sectional and longitudinal relationship.
    J Gastroenterol. 2025 Sep 28. doi: 10.1007/s00535-025-02304.
    PubMed    
    Abstract available

  100. KARKRA R
    The Association Between Night Shifts and Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Oct 1. doi: 10.1111/jgh.70101.
    PubMed    


  101. DU Y, Fan H
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Oct 7. doi: 10.1111/jgh.70113.
    PubMed    


  102. GORDON M, Benninga M, Tabbers M
    Response to "Occult constipation in pediatric IBS and FAP-NOS: Considerations on the recent ESPGHAN/NASPGHAN guidelines".
    J Pediatr Gastroenterol Nutr. 2025 Oct 22. doi: 10.1002/jpn3.70231.
    PubMed    


  103. CONTI NIBALI R, Pellegrino S, Tambucci R
    Occult constipation in pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified: Considerations on the recent ESPGHAN/NASPGHAN guidelines.
    J Pediatr Gastroenterol Nutr. 2025 Oct 22. doi: 10.1002/jpn3.70232.
    PubMed    


  104. PETERS L, Matysiak A, Hubener S, Lohse AW, et al
    Somatic symptom disorder in patients with irritable bowel syndrome or ulcerative colitis - Cross-sectional baseline findings from the SOMA.GUT-RCT.
    J Psychosom Res. 2025;198:112395.
    PubMed    
    Abstract available

  105. GAMWELL KL, Peugh JL, Santucci N, Graham K, et al
    Self-management and treatment adherence in pediatric irritable bowel syndrome (IBS): A longitudinal study.
    J Psychosom Res. 2025;198:112396.
    PubMed    
    Abstract available

  106. CHEAH S, Skvarc D, Evans S, Van Niekerk L, et al
    Exploring biopsychosocial health outcomes in endometriosis and endometriosis with co-occurring irritable bowel syndrome - A prospective cohort study.
    J Psychosom Res. 2025;199:112404.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;